Bill oversees a team of pharmacists that evaluates the drug development pipeline for new therapies, tracks FDA-mandated drug recalls and monitors drug shortages.
Bill brings over 25 years of health care experience in multiple environments including academia, managed care, hospital, medical advertising and health technology assessment. Prior to joining OptumRx Bill was director of pharmaceutical intelligence at the Institute or Clinical and Economic Review (ICER) an independent, non-profit organization focused on health technology assessment and drug pricing.
Bill holds PharmD and BS degrees from Rutgers University. He also completed a post-graduate residency in Drug Information Practice at the University of Maryland, School of Pharmacy.